Receptor.AI - Public relationsinReceptor.AITargeting cryptic pockets with Receptor.AI drug discovery platformJun 9, 2023Jun 9, 2023
Receptor.AI - Public relationsinReceptor.AIAI-based prediction of small molecules’ selectivity for highly similar protein variantsMay 16, 2023May 16, 2023
Receptor.AI - Public relationsinReceptor.AIBenchmark of the AI-augmented structure-based activity and affinity prediction methodscombined by a smart consensus functionApr 14, 2023Apr 14, 2023
Receptor.AI - Public relationsinReceptor.AIThe key for fast and efficient drug discovery: benchmarking the Receptor.AI ADMET prediction modelMar 31, 2023Mar 31, 2023
Receptor.AI - Public relationsinReceptor.AIThe rock-solid base for Receptor.AI platform: benchmarking the drug-target interaction AI modelMar 14, 2023Mar 14, 2023
Receptor.AI - Public relationsinReceptor.AIIdentification of dual-targeting Mycobacterium tuberculosis aminoacyl-tRNA synthetase inhibitors…Feb 7, 2023Feb 7, 2023
Receptor.AI - Public relationsinReceptor.AIDeveloping bifunctional protein degraders for difficult-to-drug proteins with the Receptor.AIJan 30, 2023Jan 30, 2023
Receptor.AI - Public relationsinReceptor.AIReceptor.AI introduces 3DProtDTA — the next generation drug-target interaction AI modelModel description and performance benchmarks.Jan 18, 2023Jan 18, 2023
Receptor.AI - Public relationsinReceptor.AIReceptor.AI’s end-to-end drug discovery platform avoids computational overkill and embraces…The companies, which provide drug discovery services, deal with two different types of customer requests. One of them is a request to help…Jan 8, 2023Jan 8, 2023
Receptor.AI - Public relationsinReceptor.AIThe lipid membranes are druggable and available for AI-based drug designAre the lipid membranes druggable?Jan 8, 2023Jan 8, 2023
